188 related items for PubMed ID: 32916150
1. Urinary GC-MS steroid metabotyping in treated children with congenital adrenal hyperplasia.
Kamrath C, Hartmann MF, Pons-Kühnemann J, Wudy SA.
Metabolism; 2020 Nov; 112():154354. PubMed ID: 32916150
[Abstract] [Full Text] [Related]
2. Metabotypes of congenital adrenal hyperplasia in infants determined by gas chromatography-mass spectrometry in spot urine.
Kamrath C, Friedrich C, Hartmann MF, Wudy SA.
J Steroid Biochem Mol Biol; 2023 Jul; 231():106304. PubMed ID: 36990162
[Abstract] [Full Text] [Related]
3. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
Kamrath C, Wettstaedt L, Boettcher C, Hartmann MF, Wudy SA.
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):396-406. PubMed ID: 27544322
[Abstract] [Full Text] [Related]
4. Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia.
Kamrath C, Wettstaedt L, Boettcher C, Hartmann MF, Wudy SA.
J Steroid Biochem Mol Biol; 2018 Apr; 178():221-228. PubMed ID: 29277706
[Abstract] [Full Text] [Related]
5. Height Velocity Defined Metabolic Control in Children With Congenital Adrenal Hyperplasia Using Urinary Steroid GC-MS Analysis.
Kamrath C, Wettstaedt L, Hartmann MF, Wudy SA.
J Clin Endocrinol Metab; 2019 Sep 01; 104(9):4214-4224. PubMed ID: 31112272
[Abstract] [Full Text] [Related]
6. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.
Jones CM, Mallappa A, Reisch N, Nikolaou N, Krone N, Hughes BA, O'Neil DM, Whitaker MJ, Tomlinson JW, Storbeck KH, Merke DP, Ross RJ, Arlt W.
J Clin Endocrinol Metab; 2017 Jun 01; 102(6):1797-1806. PubMed ID: 27845856
[Abstract] [Full Text] [Related]
7. Delineating endogenous Cushing's syndrome by GC-MS urinary steroid metabotyping.
Braun LT, Osswald A, Zopp S, Rubinstein G, Vogel F, Riester A, Honegger J, Eisenhofer G, Constantinescu G, Deutschbein T, Quinkler M, Elbelt U, Künzel H, Nowotny HF, Reisch N, Hartmann MF, Beuschlein F, Pons-Kühnemann J, Reincke M, Wudy SA.
EBioMedicine; 2024 Jan 01; 99():104907. PubMed ID: 38128413
[Abstract] [Full Text] [Related]
8. Urinary steroidomic profiles by LC-MS/MS to monitor classic 21-Hydroxylase deficiency.
Pussard E, Travers S, Bouvattier C, Xue QY, Cosson C, Viengchareun S, Martinerie L, Lombès M.
J Steroid Biochem Mol Biol; 2020 Apr 01; 198():105553. PubMed ID: 31778802
[Abstract] [Full Text] [Related]
9. Reduced activity of 11β-hydroxylase accounts for elevated 17α-hydroxyprogesterone in preterms.
Kamrath C, Hartmann MF, Boettcher C, Wudy SA.
J Pediatr; 2014 Aug 01; 165(2):280-4. PubMed ID: 24862381
[Abstract] [Full Text] [Related]
10. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
J Clin Endocrinol Metab; 2002 May 01; 87(5):2238-44. PubMed ID: 11994370
[Abstract] [Full Text] [Related]
11. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan 01; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
12. Quantitative targeted GC-MS-based urinary steroid metabolome analysis for treatment monitoring of adolescents and young adults with autoimmune primary adrenal insufficiency.
Kamrath C, Hartmann MF, Wudy SA.
Steroids; 2019 Oct 01; 150():108426. PubMed ID: 31228484
[Abstract] [Full Text] [Related]
13. Congenital Adrenal Hyperplasia in Children: A Pilot Study of Steroid Hormones Expressed as Sex- and Age-Related Standard Deviation Scores.
Clausen CS, Ljubicic ML, Main KM, Andersson AM, Petersen JH, Frederiksen H, Duno M, Johannsen TH, Juul A.
Horm Res Paediatr; 2020 Oct 01; 93(4):226-238. PubMed ID: 33017824
[Abstract] [Full Text] [Related]
14. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
Charmandari E, Calis KA, Keil MF, Mohassel MR, Remaley A, Merke DP.
J Clin Endocrinol Metab; 2002 Jul 01; 87(7):3197-200. PubMed ID: 12107224
[Abstract] [Full Text] [Related]
15. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Irony I, Cutler GB.
Clin Endocrinol (Oxf); 1999 Sep 01; 51(3):285-91. PubMed ID: 10469007
[Abstract] [Full Text] [Related]
16. Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry.
Lawrence N, Bacila I, Dawson J, Bryce J, Ali SR, van den Akker ELT, Bachega TASS, Baronio F, Birkebaek NH, Bonfig W, van der Grinten HC, Costa EC, de Vries L, Elsedfy H, Güven A, Hannema S, Iotova V, van der Kamp HJ, Clemente M, Lichiardopol CR, Milenkovic T, Neumann U, Nordenström A, Poyrazoğlu Ş, Probst-Scheidegger U, De Sanctis L, Tadokoro-Cuccaro R, Thankamony A, Vieites A, Yavaş Z, Faisal Ahmed S, Krone N.
Clin Endocrinol (Oxf); 2022 Nov 01; 97(5):551-561. PubMed ID: 35781728
[Abstract] [Full Text] [Related]
17. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL.
J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1055-1063. PubMed ID: 31573958
[Abstract] [Full Text] [Related]
18. Treatment patterns and unmet needs in adults with classic congenital adrenal hyperplasia: A modified Delphi consensus study.
Auchus RJ, Courtillot C, Dobs A, El-Maouche D, Falhammar H, Lacroix A, Farrar M, O'Donoghue C, Anatchkova M, Cutts K, Taylor N, Yonan C, Lamotte M, Touraine P.
Front Endocrinol (Lausanne); 2022 Oct 25; 13():1005963. PubMed ID: 36465641
[Abstract] [Full Text] [Related]
19. Measurement of Salivary Adrenal-Specific Androgens as Biomarkers of Therapy Control in 21-Hydroxylase Deficiency.
Bacila I, Adaway J, Hawley J, Mahdi S, Krone R, Patel L, Alvi S, Randell T, Gevers E, Dattani M, Cheetham T, Kyriakou A, Schiffer L, Ryan F, Crowne E, Davies JH, Ahmed SF, Keevil B, Krone N.
J Clin Endocrinol Metab; 2019 Dec 01; 104(12):6417-6429. PubMed ID: 31361321
[Abstract] [Full Text] [Related]
20. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia.
Merke DP, Keil MF, Jones JV, Fields J, Hill S, Cutler GB.
J Clin Endocrinol Metab; 2000 Mar 01; 85(3):1114-20. PubMed ID: 10720048
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
